SERUM ERYTHROPOIETIN CONCENTRATIONS AND IRON STATUS IN PATIENTS ON CHRONIC-HEMODIALYSIS

被引:0
|
作者
SEGUCHI, C
SHIMA, T
MISAKI, M
TAKARADA, Y
OKAZAKI, T
机构
[1] MIE UNIV,SCH MED,DEPT INTERNAL MED 3,TSU,MIE 514,JAPAN
[2] MIE UNIV,CTR STUDENT HLTH,TSU,MIE 514,JAPAN
[3] NATL TSU HOSP,HISAI,MIE 51411,JAPAN
关键词
IRON-BINDING CAPACITY; FERRITIN; ANEMIA; RADIOIMMUNOASSAY; CHRONIC RENAL FAILURE;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We studied the relationship between serum erythropoietin (EPO) concentration and iron status in 67 patients undergoing chronic hemodialysis. Serum concentrations of EPO were measured by RIA with recombinant human EPO. The geometric mean of the serum EPO concentration was 10.9 int. units/L (mean +/- SD range = 7.8 - 15.3 int. units/L) in hemodialysis patients, considerably lower than that in normal subjects (12.9 int. units/L). We found no significant correlation between concentrations of serum EPO and hemoglobin in hemodialysis patients, but found a significant negative correlation between serum concentrations of EPO and iron in hemodialysis patients. Moreover, we also found a significant positive correlation between the EPO concentration and the unsaturated iron-binding capacity (UIBC) in serum, and a significant negative correlation between the serum concentrations of EPO and ferritin in hemodialysis patients. Several patients who had relatively high EPO concentrations for hemodialysis patients also had low iron concentrations, high UIBC values, and low ferritin concentrations. These findings suggest that iron was utilized even at these EPO concentrations, which were very low for the degree of anemia observed in the hemodialysis patients.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 50 条
  • [31] AN EVALUATION OF SERUM FERRITIN DETERMINATION IN CHRONIC-HEMODIALYSIS PATIENTS WITH PERSISTENT LOW SERUM IRON CONCENTRATION
    ISEKI, K
    FUJIMI, S
    ONOYAMA, K
    FUJISHIMA, M
    MINERAL AND ELECTROLYTE METABOLISM, 1988, 14 (05) : 257 - 261
  • [32] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ON NUTRITIONAL-STATUS OF 16 CHRONIC-HEMODIALYSIS PATIENTS
    BYHAM, L
    FASEB JOURNAL, 1991, 5 (05): : A1084 - A1084
  • [33] A CONTROLLED-STUDY OF RECOMBINANT ERYTHROPOIETIN (EPO) IN CHRONIC-HEMODIALYSIS PATIENTS
    VANSTONE, JC
    JONES, ME
    HIRES, CE
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 240 - 240
  • [34] CHANGE OF SERUM CHROMIUM LEVEL IN CHRONIC-HEMODIALYSIS PATIENTS
    MINAMI, T
    SAMUKAWA, K
    ADACHI, K
    OKAZAKI, Y
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1984, 104 (07): : 816 - 818
  • [35] ERYTHROPOIETIN, OXYGEN-TRANSPORT AND FERROKINETICS IN ANEMIA OF CHRONIC-HEMODIALYSIS PATIENTS
    MATSIS, C
    PAPADOGIANNAKIS, N
    PAPATRIANTAFILLOU, M
    MOUTAFIS, S
    PAPASOTIRIOU, J
    BOURDECA, P
    KARAKLIS, A
    KIDNEY INTERNATIONAL, 1991, 39 (01) : 202 - 202
  • [36] SERUM FERRITIN AND HEMOCHROMATOSIS ALLELES IN CHRONIC-HEMODIALYSIS PATIENTS
    CARRERA, F
    ANDRADE, JCS
    SILVA, FJ
    SIMOES, J
    NEPHRON, 1988, 50 (03): : 196 - 198
  • [37] SERUM BIOTIN LEVELS IN PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS
    LIVANIOU, E
    EVANGELATOS, GP
    ITHAKISSIOS, DS
    YATZIDIS, H
    KOUTSICOS, DC
    NEPHRON, 1987, 46 (03): : 331 - 332
  • [38] ERYTHROPOIETIN (EPO) ENDOVENOUS VERSUS SUBCUTANEOUS TO PATIENTS ON CHRONIC-HEMODIALYSIS (CH)
    AMAYA, L
    BONELLI, CA
    PEREZ, N
    CHAMORRO, A
    OLMOS, Z
    BRUSCO, P
    VELAZQUEZ, J
    GUITIAN, N
    CASTRO, I
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1413 - 1413
  • [39] A CONTROLLED-STUDY OF RECOMBINANT ERYTHROPOIETIN (EPO) IN CHRONIC-HEMODIALYSIS PATIENTS
    VANSTONE, JC
    JONES, ME
    HIRES, CE
    CLINICAL RESEARCH, 1987, 35 (06): : A905 - A905
  • [40] EFFICACY OF LOW-DOSE HUMAN ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    SOLOZABAL, C
    MADUELL, F
    FONSECA, F
    UNZUE, J
    ASIN, J
    KIDNEY INTERNATIONAL, 1991, 40 (02) : 355 - 355